Haines and colleagues who proposed a scoring system to predict risks associated with implantable cardioverter-defibrillator (ICD) implant procedures by analyzing data from the national ICD Registry. Procedural facts related to the study are presen...
Objectives To determine the effect of the adoption of ICD on patient safety, particularly with respect to physician volume and early outcomes. Design Retrospective cohort of all ICD implantations in New York state from 1997 to 2006, with follow-up at 90 days and 1 year. ...
The implantable cardioverter-defibrillator (ICD) can be lifesaving in patients with syncope who are at risk for a malignant ventricular arrhythmia; however, determining which patients have life-threatening arrhythmias and can benefit from an ICD is challenging. ...
The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy. Heart. 2012;98:116–25. This study describes clinical outcomes in 334 patients with HCM and risk of SCD who underwent ICD implantation. Inappropriate shocks and/...
Defibrillation Testing at ICD Implantation. Background: There is uncertainty about the proper role of defibrillation testing (DT) at the time of implantable cardioverter defibrillator (ICD) insertion.Methods: A prospective registry was conducted at 13 sites in Canada between January 2006 and October ...
OBJECTIVE: Implantable cardioverter defibrillators (ICDs) are routinely used to prevent sudden cardiac death (SCD) in selected hypertrophic cardiomyopathy (HCM) patients, but the determinants of device-related complications, therapies and long-term cardiovascular mortality in ICD recipients are not known....
International Classification of DiseasesRiskcategoriesagreementSince 1965 transvenous lead implantation for cardiac pacing has been the routine treatment for bradyarrhythmias. At the end of 1980s, the implantable car-dioverter defibrillator (ICD) was considered the first-line therapy for tach-yarrhythmia ...
Furthermore, risk prediction models that differentiate between CKD patients who will and will not benefit from ICD implantation need to be developed and prospectively validated to ensure optimal sel...Goldenberg, I., & Moss, A. J. (2008). Implantable cardioverter defibrillator efficacy and chronic...
Since 1965 transvenous lead implantation for cardiac pacing has been the routine treatment for bradyarrhythmias. At the end of 1980s, the implantable car- dioverter defibrillator (ICD) was considered the first-line therapy for tach- yarrhythmia management, and in recent years new ICD indications ...
Furthermore, risk prediction models that differentiate between CKD patients who will and will not benefit from ICD implantation need to be developed and prospectively validated to ensure optimal sel...Goldenberg, I., & Moss, A. J. (2008). Implantable cardioverter defibrillator efficacy and chronic...